Rina-S: Data readout from P3 RAINFOL-02 trial (NCT06619236) for platinum resistant ovarian cancer in 2026 (Genmab A/S) - Jun 3, 2025 - ASCO 2025: Data from RAINFOL-03 trial for 2L endometrial cancer in 2027; Initiation of trial for 2L+ platinum sensitive ovarian cancer in H2 2025; Data from trial for 2L+ platinum sensitive ovarian cancer in 2028
Clinical data • New trial • P3 data • Platinum resistant • Platinum sensitive • Gynecologic Cancers • Oncology • Ovarian Cancer
|